Dukhee B Lew

Dukhee B Lew

Auto-generated profile, based on publicly available information

Dukhee B Lew

Department of Pediatrics, and UTHSC (University of Tennessee Health Science Center), Memphis, Tennessee, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
JLJennifer Lan
Jennifer Lan
ALAmit Lahoti
Amit Lahoti
DLD. Betty Lew
D. Betty Lew

3 February 2010 in Clinical and Molecular Allergy
Verified
Journal Article
Open access
PDF file
CNCyrus H Nozad
Cyrus H Nozad
LML Madison Michael
L Madison Michael
DLD Betty Lew
D Betty Lew
CMChristie F Michael
Christie F Michael
Rhinitis is characterized by rhinorrhea, sneezing, nasal congestion, nasal itch and/or postnasal drip. Often the first step in arriving at a diagnosis is to exclude or diagnose sensitivity to inhalant allergens. Non-allergic rhinitis (NAR) comprises multiple distinct conditions that may even co-exist with allergic rhinitis (AR). They may differ in their presentation and treatment. As well, the pathogenesis of NAR is not clearly elucidated and likely varied. There are many conditions that can have similar presentations to NAR or AR, including nasal polyps, anatomical/mechanical factors, autoimmune diseases, metabolic conditions, genetic conditions and immunodeficiency. Here we present a case of a rare condition initially diagnosed and treated as typical allergic rhinitis vs. vasomotor rhinitis, but found to be something much more serious. This case illustrates the importance of maintaining an appropriate differential diagnosis for a complaint routinely seen as mundane. The case presentation is followed by a review of the potential causes and pathogenesis of NAR.

1 January 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
DLD. Betty Lew
D. Betty Lew
CMChristie F. Michael
Christie F. Michael
TOTracie Overbeck
Tracie Overbeck
WRW. Scout Robinson
W. Scout Robinson
ERErin L. Rohman
Erin L. Rohman
MGM. Waleed Gaber
M. Waleed Gaber
One of the unmet needs for asthma management is a new therapeutic agent with both anti-inflammatory and anti-smooth muscle (ASM) remodeling effects. The mannose receptor (MR) family plays an important role in allergen uptake and processing of major allergens Der p 1 and Fel d 1. We have previously reported that ASM cells express a mannose receptor (ASM-MR) and that mannan derived fromSaccharomyces cerevisiae(SC-MN) inhibits mannosyl-rich lysosomal hydrolase-induced bovine ASM cell proliferation. Using a humanized transgenic mouse strain (huASM-MRC2) expressing the human MRC2 receptor in a SM tissue-specific manner, we have demonstrated that ASM hyperplasia/hypertrophy can occur as early as 15 days after allergen challenge in this mouse model and this phenomenon is preventable with SC-MN treatment. This proof-of-concept study would facilitate future development of a potential asthma therapeutic agent with dual function of anti-inflammatory and anti-smooth muscle remodeling effects.

29 November 2011 in Clinical and Molecular Allergy
Verified
Journal Article
Open access
PDF file
WRWilson S Robinson
Wilson S Robinson
SASandra R Arnold
Sandra R Arnold
CMChristie F Michael
Christie F Michael
JVJohn D Vickery
John D Vickery
RSRobert A Schoumacher
Robert A Schoumacher
DLDukhee B Lew
Dukhee B Lew
Type 1 hyper IgE syndrome (HIES), also known as Job's Syndrome, is an autosomal dominant disorder due to defects in STAT3 signaling and Th17 differentiation. Symptoms may present during infancy but diagnosis is often made in childhood or later. HIES is characterized by immunologic and non-immunologic findings such as recurrent sinopulmonary infections, recurrent skin infections, multiple fractures, atopic dermatitis and characteristic facies. These manifestations are accompanied by elevated IgE levels and reduced IL-17 producing CD3+CD4+ T cells. Diagnosis in young children can be challenging as symptoms accumulate over time along with confounding clinical dilemmas. A NIH clinical HIES scoring system was developed in 1999, and a more recent scoring system with fewer but more pathogonomonic clinical findings was reported in 2010. These scoring systems can be used as tools to help in grading the likelihood of HIES diagnosis. We report a young child ultimately presenting with disseminated histoplasmosis and a novel STAT3 variant in the SH2 domain.

1 January 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
CMChristie F. Michael
Christie F. Michael
CWChristopher M. Waters
Christopher M. Waters
KLKim S. LeMessurier
Kim S. LeMessurier
Amali SamarasingheAmali Samarasinghe
Amali Samarasinghe
CSChi Y. Song
Chi Y. Song
DLD. Betty Lew
D. Betty Lew
In asthmatic airways, repeated epithelial damage and repair occur. No current therapy directly targets this process. We aimed to determine the effects of mannan derived from S. cerevisiae (SC-MN) on airway epithelial wound repair, in vitro. The presence of functional mannose receptors in bronchial epithelial cells was shown by endocytosis of colloidal gold-Man BSA via clathrin-coated pits in 16HBE cells. In primary normal human bronchial epithelial cells (NHBEC), SC-MN significantly facilitated wound closure. Treatment with SC-MN stimulated cell spreading as indicated by a significant increase in the average lamellipodial width of wound edge 16HBE cells. In addition, NHBEC treated with SC-MN showed increased expression and activation of Krüppel-like factors (KLFs) 4 and 5, transcription factors important in epithelial cell survival and regulation of epithelial-mesenchymal transition. We conclude that SC-MN facilitates wound repair in human bronchial epithelium, involving mannose receptors.

6 October 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
Amali SamarasingheAmali Samarasinghe
Amali Samarasinghe
RPRhiannon Penkert
Rhiannon Penkert
JHJulia Hurwitz
Julia Hurwitz
RSRobert E. Sealy
Robert E. Sealy
KLKim S. LeMessurier
Kim S. LeMessurier
DLD. Betty Lew
D. Betty Lew
Asthma affects over 8% of the pediatric population in the United States, and Memphis, Tennessee has been labeled an asthma capital. Plasma samples were analyzed for biomarker profiles from 95 children with severe asthma and 47 age-matched, hospitalized nonasthmatic controls at Le Bonheur Children’s Hospital in Memphis, where over 4000 asthmatics are cared for annually. Asthmatics exhibited significantly higher levels of periostin, surfactant protein D, receptor for advanced glycation end products and β-hexosaminidase compared to controls. Children with severe asthma had lower levels of IgG1, IgG2 and IgA, and higher levels of IgE compared to controls, and approximately half of asthmatics exhibited IgG1 levels that were below age-specific norms. Vitamin A levels, measured by the surrogate retinol-binding protein, were insufficient or deficient in most asthmatic children, and correlated positively with IgG1. Which came first, asthma status or low levels of vitamin A and immunoglobulins? It is likely that inflammatory disease and immunosuppressive drugs contributed to a reduction in vitamin A and immunoglobulin levels. However, a nonmutually exclusive hypothesis is that low dietary vitamin A caused reductions in immune function and rendered children vulnerable to respiratory disease and consequent asthma pathogenesis. Continued attention to nutrition in combination with the biomarker profile is recommended to prevent and treat asthma in vulnerable children.